Arovella Therapeutics Ltd has released a press release.
Anagrelide patent for the United States
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Arovella Therapeutics: Proposed issue of securities - ALA
- Application for quotation of securities - ALA
- Update - Proposed issue of securities - ALA
- Arovella SPP Closed early over subscribed
- Investor Presentation
Later from Arovella Therapeutics
- Services Agreement with Q-Gen for CAR19-iNKT manufacture
- Adopts WEF Framework For ESG Reporting
- ZolpiMist Launch Australia
- Sumatriptan Update
- Quarterly Appendix 4C and Activities Report
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics